 Hyperphosphatemia
"Hyperphosphatemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
| Descriptor ID |
D054559
|
| MeSH Number(s) |
C18.452.750.199
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperphosphatemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperphosphatemia".
This graph shows the total number of publications written about "Hyperphosphatemia" by people in Harvard Catalyst Profiles by year, and whether "Hyperphosphatemia" was a major or minor topic of these publication.
Below are the most recent publications written about "Hyperphosphatemia" by people in Profiles.
-
Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol. 2012 Aug; 23(8):1407-15.
-
Takei Y, Yamamoto H, Sato T, Otani A, Kozai M, Masuda M, Taketani Y, Muto-Sato K, Lanske B, Takeda E. Stanniocalcin 2 is associated with ectopic calcification in a-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells. Bone. 2012 Apr; 50(4):998-1005.
-
Ohnishi M, Kato S, Razzaque MS. Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice. Biochem Biophys Res Commun. 2011 Nov 25; 415(3):434-8.
-
Razzaque MS. Osteo-renal regulation of systemic phosphate metabolism. IUBMB Life. 2011 Apr; 63(4):240-7.
-
Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol. 2011 Mar; 6(3):620-9.
-
Izzi B, Decallonne B, Devriendt K, Bouillon R, Vanderschueren D, Levtchenko E, de Zegher F, Van den Bruel A, Lambrechts D, Van Geet C, Freson K. A new approach to imprinting mutation detection in GNAS by Sequenom EpiTYPER system. Clin Chim Acta. 2010 Dec 14; 411(23-24):2033-9.
-
Hofman-Bang J, Martuseviciene G, Santini MA, Olgaard K, Lewin E. Increased parathyroid expression of klotho in uremic rats. Kidney Int. 2010 Dec; 78(11):1119-27.
-
Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009 Oct; 54(4):619-37.
-
Bergwitz C, Jüppner H. Disorders of phosphate homeostasis and tissue mineralisation. Endocr Dev. 2009; 16:133-56.
-
Razzaque MS. Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant. 2009 Jan; 24(1):4-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|